All Stories

  1. The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review
  2. Use of a folded lip‐to‐nose flap for unilateral reconstruction of the nasal planum in a dog
  3. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma
  4. Collision tumour of two nodal metastases (adenocarcinoma and mast cell tumour) in a dog
  5. Toxicity of cytarabine constant rate infusion in dogs with high‐grade non‐Hodgkin lymphoma with bone marrow or central nervous system involvement
  6. Retrospective comparison of first line adjuvant anthracycline vs metronomic‐based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma
  7. Investigation of thyroid function in dogs treated with the tyrosine kinase inhibitor toceranib
  8. Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: a single centre's experience
  9. Paraneoplastic immune-mediated neutropenia in a dog following thymoma excision with later development of metastatic thymic carcinoma treated with toceranib phosphate
  10. External beam radiotherapy for the treatment of feline salivary gland carcinoma: six new cases and a review of the literature
  11. Acute radiotherapy toxicity in 57 dogs with gross and microscopic mast cell tumours
  12. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas
  13. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study
  14. Toxicity and response in cats with neoplasia treated with toceranib phosphate